follicular lymphoma (FL)

January 28, 2020January 28, 2020

TG Therapeutics Seeks Accelerated FDA Approval of Umbralisib for Marginal Zone and Follicular Lymphomas

News

TG Therapeutics is seeking accelerated approval in the U.S. for its investigational oral therapy umbralisib to treat patients with marginal zone lymphoma (MZL) and follicular lymphoma (FL) who failed to ... Read more

January 2, 2020January 2, 2020

Revlimid-Rituximab Combo Approved in Europe for Previously Treated Follicular Lymphoma

News

The European Commission has approved Bristol-Myers Squibb‘s Revlimid (lenalidomide) in combination with rituximab to treat adults with follicular lymphoma who are no longer responding to other therapies. The combination is the first chemotherapy-free treatment ... Read more

December 5, 2019

CHMP Favors Revlimid-Rituximab Combo for Advanced Follicular Lymphoma Patients in EU

News

A branch of the European Medicines Agency voiced support for Revlimid (lenalidomide) in combination with rituximab becoming a treatment option for adults with follicular lymphoma who responded poorly to, or whose disease returned ... Read more

March 26, 2019

Trials to Test Abexinostat in Heavily Treated DLBCL, Follicular Lymphoma

News

Xynomic Pharma is preparing two new Phase 2 trials in China to explore the activity of its investigational HDAC inhibitor, abexinostat, as third-line therapy for diffuse large B-cell lymphoma (DLBCL) ... Read more

November 2, 2018November 1, 2018

I Find Hope in Cancer-themed Humor

Columns, Things That Give Me Hope - a Column by Bob McEachern

I have a confession: I like cancer humor. I would share a cancer joke, but I know it’s not everyone’s thing. Some people are offended by it. Some are saddened ... Read more

September 20, 2018

Older Stem Cell Transplant Patients with Non-Hodgkin’s Lymphoma at Higher Risk of Death, Study Suggests

News

Stem cell transplant to treat non-Hodgkin’s lymphoma in patients older than 65 is as effective as it is in younger patients, but is associated with a higher risk of non-relapse ... Read more

September 5, 2018

Follicular Lymphoma Patients with Private Insurance in US Show Better Overall Survival Rates Than Others, Study Reports

News

Follicular lymphoma patients in the U.S. with private insurance are about twice as likely to survive their cancer than those without health insurance or covered by public plans like Medicare or ... Read more

May 16, 2017

Injected Rituxan Is as Effective and Safe as IV Form as Lymphoma Treatment, Study Concludes

News

Injections of Rituxan (rituximab) for non-Hodgkin lymphoma are as effective as intravenous administrations, take five minutes instead of an hour and a half, and require far less medical-staff monitoring time, according to ... Read more